Request Deal Involvement

BridgeBio Pharma to merge with Eidos Therapeutics in a $175m deal.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Skadden Arps Slate Meagher & Flom

legal advisors

Skadden Arps Slate Meagher & Flom

JP Morgan

financial advisors

JP Morgan

Goldman Sachs

financial advisors

Goldman Sachs

Sodali & Co

financial advisors

Sodali & Co

Centerview Partners

financial advisors

Centerview Partners

Cravath Swaine & Moore

legal advisors

Cravath Swaine & Moore

or

Principals

BRIDGEBIO PHARMA LLC

bidder

BRIDGEBIO PHARMA LLC

EIDOS THERAPEUTICS

target

EIDOS THERAPEUTICS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - BridgeBio Pharma to merge with Eidos Therapeutics in a $175m deal.